Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins.

The global pharmaceutical market is valued at $1.7 trillion, offering lucrative investment prospects. Choosing the right pharmaceutical stocks involves evaluating consistent revenue growth and robust ...

The company's pipeline features almost 40 programs in late-stage clinical testing. These clinical trials are testing new drug candidates and seeking additional approvals for drugs such as Tremfya.

Indivior PLC (NASDAQ:INDV) is one of the best performing pharma stocks in 2025. Indivior PLC (NASDAQ:INDV) announced its full-year 2026 financial guidance on January 8, reporting that the total net ...

With its strengthening growth prospects, Teva may be the best healthcare stock to put $1,000 into right now. Here's why. Image source: Getty Images.

This darling of the Covid era has given back considerable gains in recent years, but it could be on the verge of a turnaround ...

Over the next 5 years, Gland Pharma plans to invest approximately Rs 20 bn in capex, primarily towards BFS and ophthalmic lines as well as capex towards CDMO contracts. Brownfield expansions will ...

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is one of the best performing pharma stocks in 2025. Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) announced on January 8 the selection of AMX0318 as a ...